Intraoperative identification of liver cancer microfoci using a targeted near-infrared fluorescent probe for imaging-guided surgery

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zeng, Chaoting ^a,b   Shang, Wenting ^b,c   Wang, Kun ^b,c   Chi, Chongwei ^b,c   Jia, Xiaohua ^b,c   Feng, Cheng ^a   Yang, Du ^b,c   Ye, Jinzuo ^b   Fang, Chihua ^a   Tian, Jie ^b,c  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF AUTOMATION   (China)

^c Beijing National Laboratory of Molecular Sciences   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYL-GLYCYL-ASPARTIC ACID; FLUORESCENT DYE; INDOCYANINE GREEN; NANOPARTICLE; OLIGOPEPTIDE; SILICON DIOXIDE;

ANIMAL; BAGG ALBINO MOUSE; COMPUTER ASSISTED SURGERY; DIAGNOSTIC IMAGING; FEMALE; FLUORESCENCE IMAGING; HEP-G2 CELL LINE; HUMAN; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MOUSE; NUDE MOUSE; PROCEDURES; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; FEMALE; FLUORESCENT DYES; HEP G2 CELLS; HETEROGRAFTS; HUMANS; INDOCYANINE GREEN; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; OLIGOPEPTIDES; OPTICAL IMAGING; SILICON DIOXIDE; SURGERY, COMPUTER-ASSISTED;

EID: 84988592799     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep21959     Document Type: Article

References (47)

1. El-Serag H. B. Hepatocellular carcinoma. N Engl J Med 365, 1118-1127 (2011).
2. Nguyen, Q. T. & Tsien, R. Y. Fluorescence-guided surgery with live molecular navigation [mdash] a new cutting edge. Nat Rev Cancer 13, 653-662 (2013).
3. Wyld, L., Audisio, R. A. & Poston, G. J. The evolution of cancer surgery and future perspectives. Nat Rev Clin Oncol 12, 115-124 (2015).
4. Urano, Y. et al. Rapid cancer detection by topically spraying a gamma-glutamyltranspeptidase-activated fluorescent probe. Sci Transl Med 3, 110ra119 (2011).
5. Frangioni, J. V. New technologies for human cancer imaging. J Clin Oncol 26, 4012-4021 (2008).
6. Forner, A., Llovet, J. M. & Bruix, J. Hepatocellular carcinoma. Lancet 379, 1245-1255 (2012).
7. Vinegoni, C. et al. Indocyanine green enables near-infrared fluorescence imaging of lipid-rich, inflamed atherosclerotic plaques. Sci Transl Med 3, 84ra45 (2011).
8. Huang, R. et al. Integrin alphavbeta3-targeted IRDye 800CW near-infrared imaging of glioblastoma. Clin Cancer Res 18, 5731-5740 (2012).
9. Terwisscha van Scheltinga, A. G. et al. Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies. J Nucl Med 52, 1778-1785 (2011).
10. Chi, C. et al. Increased precision of orthotopic and metastatic breast cancer surgery guided by matrix metalloproteinase-activatable near-infrared fluorescence probes. Sci Rep 5, 14197 (2015).
11. van den Berg, N. S. et al. Multimodal Surgical Guidance during Sentinel Node Biopsy for Melanoma: Combined Gamma Tracing and Fluorescence Imaging of the Sentinel Node through Use of the Hybrid Tracer Indocyanine Green-(99 m)Tc-Nanocolloid. Radiology 275, 521-529 (2015).
12. Liu, Y. et al. First in-human intraoperative imaging of HCC using the fluorescence goggle system and transarterial delivery of nearinfrared fluorescent imaging agent: a pilot study. Transl Res 162, 324-331 (2013).
13. van der Vorst, J. R. et al. Near-infrared fluorescence-guided resection of colorectal liver metastases. Cancer 119, 3411-3418 (2013).
14. Weissleder, R. & Pittet, M. J. Imaging in the era of molecular oncology. Nature 452, 580-589 (2008).
15. Hu, K. et al. In Vivo Cancer Dual-Targeting and Dual-Modality Imaging with Functionalized Quantum Dots. J Nucl Med 56, 1278-1284 (2015).
16. Weissleder, R., Tung, C. H., Mahmood, U. & Bogdanov, A. Jr. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 17, 375-378 (1999).
17. Pasqualini, R., Koivunen, E. & Ruoslahti, E. Alpha v integrins as receptors for tumor targeting by circulating ligands. Nat Biotechnol 15, 542-546 (1997).
18. Kobayashi, H. & Choyke, P. L. Target-cancer-cell-specific activatable fluorescence imaging probes: rational design and in vivo applications. Acc Chem Res 44, 83-90 (2011).
19. Ruggiero, A. et al. Targeting the internal epitope of prostate-specific membrane antigen with 89Zr-7E11 immuno-PET. J Nucl Med 52, 1608-1615 (2011).
20. Hyun, H. et al. Structure-inherent targeting of near-infrared fluorophores for parathyroid and thyroid gland imaging. 21, 192-197 (2015).
21. Ghosh, D. et al. Deep, noninvasive imaging and surgical guidance of submillimeter tumors using targeted M13-stabilized singlewalled carbon nanotubes. Proc Natl Acad Sci USA 111, 13948-13953 (2014).
22. Hu, Z. et al. In vivo nanoparticle-mediated radiopharmaceutical-excited fluorescence molecular imaging. Nat Commun. 6, 7560 (2015).
23. Jokerst, J. V., Khademi, C. & Gambhir, S. S. Intracellular aggregation of multimodal silica nanoparticles for ultrasound-guided stem cell implantation. Sci Transl Med 5, 177ra135 (2013).
24. Tang, F., Li, L. & Chen, D. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater 24, 1504-1534 (2012).
25. Vivero-Escoto, J. L., Huxford-Phillips, R. C. & Lin, W. Silica-based nanoprobes for biomedical imaging and theranostic applications. Chem Soc Rev 41, 2673-2685 (2012).
26. Tarn, D. et al. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility. Acc Chem Res 46, 792-801 (2013).
27. Shaffer, T. M. et al. Silica nanoparticles as substrates for chelator-free labeling of oxophilic radioisotopes. Nano Lett 15, 864-868 (2015).
28. Benezra, M. et al. Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J Clin Invest 121, 2768-2780 (2011).
29. Desgrosellier, J. S. & Cheresh, D. A. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 10, 9-22 (2010).
30. Sun, T. et al. Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed Engl 53, 12320-12364 (2014).
31. Loveman, E. et al. The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation. Health Technol Assess 18, vii-viii, 1-283 (2014).
32. Pagani, O. et al. International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured? J Natl Cancer Inst 102, 456-463 (2010).
33. Eckhardt, B. L., Francis, P. A., Parker. B. S. & Anderson, R. L. Strategies for the discovery and development of therapies for metastatic breast cancer. Nat Rev Drug Discov 11, 479-497 (2012).
34. Gotoh, K. et al. A novel image-guided surgery of hepatocellular carcinoma by indocyanine green fluorescence imaging navigation. J Surg Oncol 100, 75-79 (2009).
35. Schaafsma, B. E. et al. The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol 104, 323-332 (2011).
36. van Dam, G. M. et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results. Nat Med 17, 1315-1319 (2011).
37. Mondal, S. B. et al. Binocular Goggle Augmented Imaging and Navigation System provides real-time fluorescence image guidance for tumor resection and sentinel lymph node mapping. Sci Rep 5, 12117 (2015).
38. Gilmore, D. M. et al. Effective low-dose escalation of indocyanine green for near-infrared fluorescent sentinel lymph node mapping in melanoma. An Surg Oncol 20, 2357-2363 (2013).
39. Gilmore, D. M. et al. Identification of metastatic nodal disease in a phase 1 dose-escalation trial of intraoperative sentinel lymph node mapping in non-small cell lung cancer using near-infrared imaging. J Thorac Cardiovasc Surg 146, 562-570 discussion 569-570 (2013).
40. Tajima, Y. et al. Sentinel node mapping guided by indocyanine green fluorescence imaging in gastric cancer. An Surg 249, 58-62 (2009).
41. Liao, Y. T., Liu, C. H., Yu, J. & Wu, K. C. Liver cancer cells: targeting and prolonged-release drug carriers consisting of mesoporous silica nanoparticles and alginate microspheres. Int J Nanomedicine 9, 2767-2778 (2014).
42. Choi, K. Y. et al. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy. ACS Nano 5, 8591-8599 (2011).
43. Feron, O. Tumor-penetrating peptides: a shift from magic bullets to magic guns. Sci Transl Med 2, 34ps26 (2010).
44. Chen, D., Li, L., Tang, F. & Qi, S. Facile and scalable synthesis of tailored silica "nanorattle" structures. Adv Mater 21, 3804-3807 (2009).
45. Li, L. et al. Silica nanorattle-doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy. ACS Nano 5, 7462-7470 (2011).
46. Crisp, J. L. et al. Dual targeting of integrin alphavbeta3 and matrix metalloproteinase-2 for optical imaging of tumors and chemotherapeutic delivery. Mol Cancer Ther 13, 1514-1525 (2014).
47. Chi, C. et al. Intraoperative imaging-guided cancer surgery: from current fluorescence molecular imaging methods to future multimodality imaging technology. Theranostics 4, 1072-1084 (2014).